Showing 51-60 of 3945 results for "".
Journal Club: Biologics for Young Children
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RExciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.Interoperability Redux
https://practicaldermatology.com/topics/practice-management/interoperability-redux/20455/Is the new push for interoperability déjà vu all over again?DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit
https://practicaldermatology.com/topics/psoriasis/dermwiretv-incytes-opzelura-bms-patient-week-science-of-skincare-summit/20003/Incyte’s Opzelura is the first topical JAK inhibitor approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global PBurnout: Is Personal Happiness the Answer?
https://practicaldermatology.com/programs/practical-dermatology/burnout-is-personal-happiness-the-answer/18191/Physician burnout remains a conversation, and the pandemic dramatically changed the landscape for dermatologists—for better and for worse. Omaha, NE-based Joel Schlessinger, MD, who serves as Chief Cosmetic Surgery Editor of Practical Dermatology® speaks with Las Vegas-based dermatologist H.L. GreenHow to Deal with Hagglers and Other Tough Patients
https://practicaldermatology.com/topics/practice-management/how-to-deal-with-hagglers-and-other-tough-patients/19211/Michael J. Sacopulos, JD offers strategies for handling difficult patients and how to negotiate with hagglers.TELEMEDICINE AND ONLINE PRESENCE
https://practicaldermatology.com/topics/practice-management/matv-sacopulos-2--ahooremm/19114/Is telemedicine the next wave of medical practice? Michael J. Sacopulos, JD (www.medriskinstitute.com) weighs in.IDAS, LBO Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/idas-lbo-laser-system-by-quantel-derma/19373/IDAS by Quantel Derma - Green Light for Mobile Power. IDAS is the powerful LBO laser system with 532 nm wavelength for vascular indications such as rosacea or telangiectasia and pigmented skin changes. Its 8 watt power make treatments very effective. Due to its robust technology, IDAS has an officiaAdvocating for the Specialty and Patient Safety
https://practicaldermatology.com/topics/practice-management/advocating-for-the-specialty-and-patient-safety/18702/George J. Hruza, MD, Past President of the American Society for Dermatologic Surgery (ASDS), sat down with DermTube Journal Club Host Nancy J. Samolitis, MD to discuss the importance of getting involved with organizations like the ASDS and the American Academy of Dermatology Association to advocateUpdates on Psoriasis Biologics
https://practicaldermatology.com/programs/practical-dermatology/updates-on-psoriasis-biologics/35894/Jashin J. Wu, MD, discusses biologics for psoriasis, including a meta-analyses of best biologics for different types of the condition, at Music City SCALE 2025.